|
Market Cap (19-May) $82,472,520 (825th) |
Close (30-Jun) $1.50 |
Volume (30-Jun) 19,997 |
Shortsold (12-Dec) 1,378 (0.00%) (711th) |
|
52w High $1.33 |
52w Low $1.10 |
P/E - |
EPS - |
CD3 released this announcement to the ASX on 1 September 2021, 13:58. The announcement is not marked as price sensitive, and is 19 page(s) in length and 1.32MB in size.
You can view all announcements from CD3 and see how they appear on a price chart on the announcements page.
At the date of this announcement, CD3 was 0.002% short sold according to ASIC data. It was ranked the 711th most shorted stock on the ASX. It remains ranked 711th as of the latest reported data (12 December 2022).
| Other Recent Announcements from CD3 | |
|---|---|
| Appendix 3Z - Final Director's Interest Notice | 30 June 2023, 10:27 |
| Appendix 3Z - Final Director's Interest Notice | 30 June 2023, 10:25 |
| Appendix 3Z - Final Director's Interest Notice | 30 June 2023, 10:22 |
| Change in substantial holding | 1 September 2021, 13:58 |
| Net Tangible Asset Backing & Fund Update | 13 August 2021, 15:38 |
| Quarterly Investment Update - June 2021 | 13 August 2021, 14:28 |
| Net Tangible Asset Backing & Fund Update | 14 July 2021, 16:31 |
You must be logged in to post a reply.
